Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Amicus Therapeutics, Inc. (FOLD) had Debt to Capital Ratio of 0.67 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$125.25M |
|
$-21.69M |
|
$11.70M |
|
$113.55M |
|
$133.20M |
|
$-7.95M |
|
$-10.09M |
|
$-18.05M |
|
$-18.05M |
|
$-21.69M |
|
$-21.69M |
|
$-21.69M |
|
$-21.69M |
|
$-7.95M |
|
$-5.51M |
|
307.69M |
|
307.69M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$510.80M |
|
$28.72M |
|
$279.04M |
|
$789.84M |
|
$152.89M |
|
$390.71M |
|
$443.39M |
|
$596.28M |
|
$193.56M |
|
$-20.63M |
|
$193.56M |
|
307.92M |
|
| Cash Flow Statement Financials | |
$7.76M |
|
$-32.86M |
|
$-11.70M |
|
$216.72M |
|
$184.73M |
|
$-31.98M |
|
$25.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.34 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.67 |
2.02 |
|
90.66% |
|
-6.35% |
|
-6.35% |
|
-- |
|
-14.41% |
|
-17.31% |
|
$7.55M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.09 |
|
1.42 |
|
63.47 |
|
-11.20% |
|
105.13% |
|
-2.75% |
|
-3.71% |
|
$0.63 |
|
$0.02 |
|
$0.03 |
|